An important event during wound healing is the contraction of newly formed connective tissue (granulation tissue) by fibroblasts. The role of polypeptide growth factors in the process of wound contraction was investigated by analyzing the influence of transforming growth factor (3 (TGF-(3), platelet-derived growth factor, fibroblast growth factor, and epidermal growth factor on the ability of fibroblasts to contract a collagen matrix in an in vitro system. TGF-J3, but not the other growth factors tested, markedly enhanced the ability of BHK-21, 3T3-L1, and human foreskin fibroblasts to contract collagen gels. These results suggest that TGF-P released from platelets and inflammatory cells at sites of tissue injury stimulates fibroblasts to contract the provisional wound matrix and that this effect contributes to the ability of TGF-13 to accelerate wound healing.
The process of wound repair involves an ordered sequence of events. Inflammatory cells first migrate into the plasma clot, followed by fibroblasts, which elaborate collagen and other matrix components (1) and which eventually contract the newly formed connective tissue to bring together the edges of the wound (2) (3) (4) . Polypeptide growth factors are thought to play important roles in tissue repair (5) . Transforming growth factor f3 (TGF-(3) is a multifunctional regulatory polypeptide present in a wide variety of tissues and is especially abundant in platelets, from which it is released at sites of injury (6) . Experimental work with animal models has demonstrated that TGF-P (7) (8) (9) , in concert with other growth factors (7, (10) (11) (12) , can promote wound healing. In vitro studies suggested that stimulation of wound healing by TGF-,l may result from the ability of the growth factor to regulate crucial steps in the repair process. Thus, TGF-,B has been shown to be chemotactic for inflammatory cells (13) and for fibroblasts (14) and to induce fibroblasts to produce increased amounts of collagen and fibronectin (8, (15) (16) (17) . Whether TGF-,B also plays a role in the contraction of the provisional wound matrix is not known.
In 1979, Bell et al. (18) reported that fibroblasts incorporated in a collagen gel induce a progressive contraction of the gel, resulting in the formation of a dense collagen disc of greatly reduced diameter. This phenomenon has been considered as an in vitro equivalent of the connective-tissue contraction that occurs during wound healing and other biological processes (18) (19) (20) (21) (22) , and it provides a simple method ofquantitating the contractile ability offibroblasts. Using this model, we have found that TGF-P powerfully enhances the ability of fibroblasts to contract a collagen matrix. Ag/ml).
MATERIALS AND METHODS
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Three-dimensional collagen gels were prepared essentially as described (23) . In brief, type I collagen was extracted by stirring adult rat tail tendons for 48 hr at 40C in a sterile 0.1% (vol/vol) acetic acid solution (300 ml for 1 g of collagen). The resulting solution was centrifuged at 16,000 x g for 1 hr at 40C. The supernatant was then extensively dialyzed against 0.1 x MEM and stored at 40C. For incorporation into collagen gels, cells were harvested from confluent cultures by using 0.05% trypsin/0.02% EDTA, counted, adjusted to the desired density, and centrifuged in a plastic tube. The tube was placed on ice, and the cell pellet was resuspended in a solution of polymerizing collagen, which was prepared by quickly mixing 8 volumes of collagen stock solution with 1 volume of 10 x concentrated MEM and 1 volume of sodium bicarbonate (11.76 mg/ml). Aliquots (2 ml) of the cold collagen mixture were dispensed into 35-mm plastic dishes (Nunc, Kampstrup, Roskilde, Denmark) and allowed to gel for about 10 min at 370C before the addition of complete culture medium. The gels were then gently detached from the walls and the bottom of the dishes by passing a curved-tip metallic spatula or Pasteur pipette around the perimeter of the gels.
To assess the effect of growth factors on gel contraction, these substances were added to the culture medium immediately after the gels were released. Culture media and growth factors were renewed at 48-hr intervals. Gel contraction was quantitated at 24-hr intervals by placing the dishes on transparent metric-scale graph paper and measuring the major and minor axes of the collagen gels with the aid of a Wild M 400 Photomacroscope (Wild, Heerbrugg, Switzerland) ( x 6.3 magnification). The area of the gels was calculated from the averaged diameters and expressed as a percentage of the initial area. To evaluate the number of cells within a collagen gel at the end of the experiment, the gels were incubated with 1.5 ml of collagenase (4 mg/ml) for 30-75 min at 370C. *To whom reprint requests should be addressed.
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was kindly provided by A. Baird (The Salk Institute, San Diego, CA). Porcine platelet-derived growth factor (98% pure, batch 60826000) was from Boehringer Mannheim (Rotkreuz, Switzerland), and epidermal growth factor was from Collaborative Research (Waltham, MA).
RESULTS
The rate of collagen-gel contraction by fibroblasts has been shown to be (i) proportional to the number of cells embedded in the gel and (ii) inversely related to the collagen concentration (18) . We have incorporated a relatively low number of cells (4 x iOs to 1 x 106 cells per gel) in gels made with a relatively high concentration of collagen (about 1.5 mg/ml). Under these conditions, untreated fibroblasts produced a slow and moderate contraction of collagen gels.
Two established fibroblast cell lines (BHK-21 and 3T3-L1 cells) as well as human foreskin fibroblasts were used in this study. After incorporation of the cells, the collagen gels were released from the walls of the dishes, and contraction was allowed to proceed in the presence or absence of TGF-/3. As shown in Fig. 1 , TGF-/3 dramatically increased the contraction ofcollagen gels by all three types offibroblasts used. The enhanced contraction was associated with a change in the appearance of the collagen disc from a translucent gel to an opaque, dense structure. Gel contraction did not occur in the absence of cells.
Fibroblast contraction of collagen gels has been shown to be dependent on the presence of serum (19) . We have found that TGF-f3 can stimulate contraction of gels in the absence of serum: in gels cast with 106 3T3-L1 cells, the degree of contraction elicited over a period of 4 days by TGF-p at 1 ng/ml in serum-free medium was greater than that observed in untreated cultures maintained in the presence of 10o FBS (Fig 1; compare f with g ). In gels cast with 4 x iOs human foreskin fibroblasts, TGF-16 at 5 ng/ml in serum-free medium produced approximately the same contraction as seen with 10%6 FBS in the absence of the growth factor (data not shown).
Under the same experimental conditions in which TGF-p8 elicited strong gel contraction, platelet-derived growth factor at 10-50 ng/ml or epidermal growth factor at 50 ng/ml had no effect on gel contraction, whether in the presence or absence of FBS. Basic fibroblast growth factor at 3 ng/ml slightly enhanced gel contraction by BHK-21 fibroblasts in 10%6 FBS but had no effect on gel contraction by 3T3-L1 and human foreskin fibroblasts.
To quantitate collagen-gel contraction, gel diameter was measured at 24-hr intervals, and the area of the gels was calculated and expressed as a percentage of the original area. The kinetics of gel contraction by BHK-21, 3T3-L1, and human foreskin fibroblasts in control medium or in the presence of various concentrations ofTGF-/3 are presented in Fig. 2 . Collagen gels populated by BHK-21 fibroblasts had not yet started to contract by day 2 of incubation in 10%o FBS and had contracted only to 84% of their initial area by day 4. Addition of TGF-f3 stimulated contraction in a dosedependent manner: in the presence of TGF-f3 at 5 ng/ml, gel area was reduced to 79o of the original area by 24 hr and to 8.6% by day 4 (Fig. 2 Top) . 3T3-L1 cells more efficiently contracted collagen gels under control conditions; enhanced contraction was observed with concentrations of TGF-3 as low as 0.1 ng/ml and was maximal at 1 ng/ml (Fig. 2 Middle). Human foreskin fibroblasts were even more responsive to TGF-p, with nearly maximal gel contraction occurring at 0.1 ng/ml (Fig. 2 started immediately after release, and gel area was reduced to 37% of the initial area by 2 hr. Over the same time period, no contraction was observed in gels released after 4 days of incubation in control medium (results not shown).
Upon termination of contraction experiments, collagen gels were digested with collagenase (4 mg/ml), and freed cells were counted with a hemocytometer. The number of human foreskin fibroblasts and 3T3-L1 cells contained within collagen gels, whether in the presence or absence of TGF-, showed no significant change during the course of the Medical Sciences: Montesano (18) (19) (20) (21) (22) have shown that fibroblasts incorporated into three-dimensional collagen gels induce a progressive contraction of the gels and that this phenomenon requires the presence of serum. We have demonstrated here that TGF-pB substitutes for serum in stimulating fibroblast contraction of collagen gels and markedly enhances the contraction normally observed in the presence of serum.
Under the same experimental conditions, platelet-derived growth factor, basic fibroblast growth factor, and epidermal growth factor did not significantly stimulate contraction of collagen gels, suggesting that this activity of TGF-P is not a general property of growth factors.
The mechanism by which TGF-p8 stimulates fibroblasts to contract collagen gels is not known. Contraction of collagen gels is thought to result from the cumulative traction exerted by fibroblasts on collagen fibrils (24) . Theoretically, TGF-j3 might either increase the force generated by the fibroblast contractile machinery, or improve the transmission of that force to the collagen matrix, or both. Increased syntheses of actin (25) , fibronectin (15) (16) (17) , and matrix receptors (26) represent potential mechanisms by which TGF-13 might enhance the efficiency of collagen-gel contraction by fibroblasts.
The ability to contract a collagen matrix in vitro is believed to represent a fibroblast function that also operates in vivo during the process of wound repair (18) (19) (20) (21) (22) . Contraction of newly formed connective tissue (granulation tissue) by phenotypically specialized fibroblasts [also called myofibroblasts (2, 4) ] is a phenomenon of great clinical importance in reducing the original size of the wound (2-4). However, if it occurred inappropriately, it could lead to excessive scarring, disfigurement, and impaired tissue function (3, 4, 27) . It is therefore important to identify the factors that govern this process. Our in vitro results strongly suggest that TGF-,8 is a physiological regulator of wound contraction. More specifically, we propose that TGF-,3 released from platelets (28) and inflammatory cells (8, 29, 30) at sites of injury stimulates wound healing (7-9) not only by recruiting fibroblasts (14) and inducing them to produce collagen and other matrix constituents (8, (15) (16) (17) but also by promoting the contraction of the provisional wound matrix. The property of TOF-f3 to stimulate connective tissue contraction by fibroblasts may also be relevant for physiopathological processes other than normal tissue repair. Thus, it is conceivable that TGF-j3 secreted by macrophages (29) and activated lymphocytes (8, 30) may play a role in the fibrocontractive response frequently associated with chronic inflammatory reactions.
